71 related articles for article (PubMed ID: 19144982)
21. The Impact of DNA Methylation in Hematopoietic Malignancies.
Guillamot M; Cimmino L; Aifantis I
Trends Cancer; 2016 Feb; 2(2):70-83. PubMed ID: 27019871
[TBL] [Abstract][Full Text] [Related]
22. [Clinical features and prognosis in MLL-AF10 positive acute leukemia].
Wang L; Qin Y; Jia J; Zhao T; Wang J; Yang S; Wen L; Lu J; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2015 Oct; 36(10):840-3. PubMed ID: 26477762
[TBL] [Abstract][Full Text] [Related]
23. The biological role of actinin-4 (ACTN4) in malignant phenotypes of cancer.
Honda K
Cell Biosci; 2015; 5():41. PubMed ID: 26288717
[TBL] [Abstract][Full Text] [Related]
24. Molecular Genetic Markers in Acute Myeloid Leukemia.
Yohe S
J Clin Med; 2015 Mar; 4(3):460-78. PubMed ID: 26239249
[TBL] [Abstract][Full Text] [Related]
25. TET1 is a tumor suppressor of hematopoietic malignancy.
Cimmino L; Dawlaty MM; Ndiaye-Lobry D; Yap YS; Bakogianni S; Yu Y; Bhattacharyya S; Shaknovich R; Geng H; Lobry C; Mullenders J; King B; Trimarchi T; Aranda-Orgilles B; Liu C; Shen S; Verma AK; Jaenisch R; Aifantis I
Nat Immunol; 2015 Jun; 16(6):653-62. PubMed ID: 25867473
[TBL] [Abstract][Full Text] [Related]
26. Theranostic impact of NG2/CSPG4 proteoglycan in cancer.
Nicolosi PA; Dallatomasina A; Perris R
Theranostics; 2015; 5(5):530-44. PubMed ID: 25767619
[TBL] [Abstract][Full Text] [Related]
27. Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene.
Othman MA; Grygalewicz B; Pienkowska-Grela B; Rincic M; Rittscher K; Melo JB; Carreira IM; Meyer B; Marzena W; Liehr T
J Histochem Cytochem; 2015 May; 63(5):384-90. PubMed ID: 25699572
[TBL] [Abstract][Full Text] [Related]
28. TET proteins and the control of cytosine demethylation in cancer.
Scourzic L; Mouly E; Bernard OA
Genome Med; 2015; 7(1):9. PubMed ID: 25632305
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic roots of immunologic disease and new methods for examining chromatin regulatory pathways.
MacDonald IA; Hathaway NA
Immunol Cell Biol; 2015 Mar; 93(3):261-70. PubMed ID: 25533290
[TBL] [Abstract][Full Text] [Related]
30. Epigenetics: an emerging player in gastric cancer.
Kang C; Song JJ; Lee J; Kim MY
World J Gastroenterol; 2014 Jun; 20(21):6433-47. PubMed ID: 24914365
[TBL] [Abstract][Full Text] [Related]
31. Detection of gene rearrangements in targeted clinical next-generation sequencing.
Abel HJ; Al-Kateb H; Cottrell CE; Bredemeyer AJ; Pritchard CC; Grossmann AH; Wallander ML; Pfeifer JD; Lockwood CM; Duncavage EJ
J Mol Diagn; 2014 Jul; 16(4):405-17. PubMed ID: 24813172
[TBL] [Abstract][Full Text] [Related]
32. Molecular characterization and clinical course of MLL-ACTN4 rearrangement in therapy-related hematologic malignancies.
Yang JJ; Park TS; Lee ST; Seo JY; Oh SH; Cho EH; Burmeister T; Ludwig WD; Meyer C; Marschalek R; Kim HJ; Kim SH
Haematologica; 2014 Apr; 99(4):e49-51. PubMed ID: 24561789
[No Abstract] [Full Text] [Related]
33. Germline variants in IKZF1, ARID5B, and CEBPE as risk factors for adult-onset acute lymphoblastic leukemia: an analysis from the GMALL study group.
Burmeister T; Bartels G; Gröger D; Trautmann H; Schwartz S; Lenz K; Tietze-Bürger C; Viardot A; Wäsch R; Horst HA; Reinhardt R; Gökbuget N; Hoelzer D; Kneba M; Brüggemann M
Haematologica; 2014 Feb; 99(2):e23-5. PubMed ID: 24497567
[No Abstract] [Full Text] [Related]
34. First description of the t(10;11)(q22;q23)/MLL-TET1 translocation in a T-cell lymphoblastic lymphoma, with subsequent lineage switch to acute myelomonocytic myeloid leukemia.
Ittel A; Jeandidier E; Helias C; Perrusson N; Humbrecht C; Lioure B; Mazurier I; Mayeur-Rousse C; Lavaux A; Thiebault S; Lerintiu F; Gervais C; Mauvieux L
Haematologica; 2013 Dec; 98(12):e166-8. PubMed ID: 24323992
[No Abstract] [Full Text] [Related]
35. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Atak ZK; Li N; Vicente C; Patchett S; Girardi T; Gianfelici V; Geerdens E; Clappier E; Porcu M; Lahortiga I; Lucà R; Yan J; Hulselmans G; Vranckx H; Vandepoel R; Sweron B; Jacobs K; Mentens N; Wlodarska I; Cauwelier B; Cloos J; Soulier J; Uyttebroeck A; Bagni C; Hassan BA; Vandenberghe P; Johnson AW; Aerts S; Cools J
Nat Genet; 2013 Feb; 45(2):186-90. PubMed ID: 23263491
[TBL] [Abstract][Full Text] [Related]
36. Genomic breakpoints and clinical features of MLL-TET1 rearrangement in acute leukemias.
Lee SG; Cho SY; Kim MJ; Oh SH; Cho EH; Lee S; Baek EJ; Choi JH; Bohlander SK; Lode L; Richebourg S; Yoon HJ; Marschalek R; Meyer C; Park TS
Haematologica; 2013 Apr; 98(4):e55-7. PubMed ID: 23100278
[No Abstract] [Full Text] [Related]
37. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
Zorko NA; Bernot KM; Whitman SP; Siebenaler RF; Ahmed EH; Marcucci GG; Yanes DA; McConnell KK; Mao C; Kalu C; Zhang X; Jarjoura D; Dorrance AM; Heerema NA; Lee BH; Huang G; Marcucci G; Caligiuri MA
Blood; 2012 Aug; 120(5):1130-6. PubMed ID: 22674806
[TBL] [Abstract][Full Text] [Related]
38. Perspectives on the causes of childhood leukemia.
Wiemels J
Chem Biol Interact; 2012 Apr; 196(3):59-67. PubMed ID: 22326931
[TBL] [Abstract][Full Text] [Related]
39. Pathogenetic, Clinical, and Prognostic Features of Adult t(4;11)(q21;q23)/MLL-AF4 Positive B-Cell Acute Lymphoblastic Leukemia.
Marchesi F; Girardi K; Avvisati G
Adv Hematol; 2011; 2011():621627. PubMed ID: 22190943
[TBL] [Abstract][Full Text] [Related]
40. Molecular diagnostics, targeted therapy, and the indication for allogeneic stem cell transplantation in acute lymphoblastic leukemia.
Oyekunle A; Haferlach T; Kröger N; Klyuchnikov E; Zander AR; Schnittger S; Bacher U
Adv Hematol; 2011; 2011():154745. PubMed ID: 22110503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
